About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Chicago | 17,804 Studies Near You

Clinical TrialsChicago

Clinical Trials in Chicago

Discover 17,804 clinical trials near Chicago, Illinois. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 5001-5020 of 17,804 trials

CompletedBasic and Clinical Research on Attention Deficit Hyperactivity Disorder (ADHD)Children between 6-17 are evaluated for ADHD and and a blood sample is obtained for DNA extraction.NCT00663442·Chicago, Illinois CompletedClinical Mismatch in the Triage of Wake Up and Late Presenting Strokes Undergoing Neurointervention With TrevoThe purpose of the study is to evaluate the hypothesis that Trevo thrombectomy plus medical management leads to superior clinical outcomes at 90 days as compared to medical…NCT02142283·Los Angeles, California and 31 others

Find Trials by Condition in Chicago

Breast Cancerin Chicago Lung Cancerin Chicago Prostate Cancerin Chicago Colorectal Cancerin Chicago Melanomain Chicago Leukemiain Chicago Lymphomain Chicago Pancreatic Cancerin Chicago Ovarian Cancerin Chicago Brain Cancerin Chicago Diabetes

Data from ClinicalTrials.govTerms

TerminatedA Study To Examine The Efficacy And Safety Of Pramlintide+Metreleptin In Obese SubjectsFollowing screening, eligible subjects will be enrolled into a 6-week Low Calorie Diet (LCD) lead-in period.NCT01235741·Greenbrae, California and 17 others

CompletedStudy to Determine Safety and Dosage of OPTISON in Pediatric ParticipantsStudy to determine the safety and appropriate dosage of OPTISON in pediatric participants since OPTISON has been tested in adult participants only during the clinical developmentNCT03740997·Phoenix, Arizona and 7 others

TerminatedDown Syndrome Clinical Trials - Study of Alzheimer's Disease in Down SyndromeThe primary objective is to characterize trajectories of change on the primary outcome measures in this study population through longitudinal collection of measures of cognition…NCT04149197·Phoenix, Arizona and 13 others

CompletedA Study of the Safety and Efficacy of Fabrazyme in Patients With Fabry DiseasePeople with Fabry Disease have an alteration in their genetic material (DNA) which causes a deficiency of the alpha-galactosidase A enzyme.NCT00081497·Birmingham, Alabama and 24 others

CompletedA Study to Compare the Use of Fluconazole as Continuous Therapy Versus Periodic Therapy in HIV-Positive Patients With Recurrent ThrushThe purpose of this study is to determine whether it is better to treat patients with fluconazole on a continuous basis to prevent thrush (yeast infection in the mouth) from…NCT00000951·Los Angeles, California and 53 others

Active not recruitingCarboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube CancerThis randomized phase III trial studies carboplatin, paclitaxel and gemcitabine hydrochloride when given together with or without bevacizumab after surgery to see how well it…NCT00565851·Anchorage, Alaska and 708 others

CompletedAndrogen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate CancerThis phase II trial studies how well androgen deprivation therapy and vorinostat followed by radical prostatectomy works in treating patients with prostate cancer that has not…NCT00589472·Los Angeles, California and 14 others

CompletedA 6-Month Study Of CP-690,550 Versus Tacrolimus In Kidney Transplant PatientsThis Phase 2 study was designed to evaluate the safety and efficacy of 2 dose levels of CP-690,550 (15 mg twice daily and 30 mg twice) against tacrolimus, in combination with…NCT00106639·Los Angeles, California and 19 others

RecruitingREMASTer: REcurrent Brain Metastases After SRS TrialRandomized, post-market multi-center study investigating the efficacy of two sets of treatment algorithms in brain metastases (BM) patients at the time of first intervention for…NCT05124912·Los Angeles, California and 8 others

CompletedP3 (Prepared, Protected, emPowered)P3 (Prepared, Protected, emPowered) is an interactive smartphone app for HIV-uninfected YMSM and YTW that utilizes social networking and game-based mechanics as well as a…NCT03320512·Tampa, Florida and 8 others

CompletedSafety and Efficacy of Amphotericin B Lipid Complex in the Treatment of Cryptococcal Meningitis in Patients With the Acquired Immunodeficiency SyndromeTo evaluate the safety, tolerance and efficacy of three different dosage regimens of Amphotericin B Lipid Complex (ABLC) compared to Fungizone (Amphotericin B) in patients with…NCT00002019·Torrance, California and 18 others

CompletedRituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's LeukemiaRATIONALE: Monoclonal antibodies such as rituximab can locate tumor cells and either kill them or deliver tumor-killing substances to them without harming normal cells.NCT00039130·San Diego, California and 30 others

CompletedRadiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder CancerRATIONALE: Radiation therapy uses x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00003930·Birmingham, Alabama and 228 others

CompletedA Multicenter Prospective Study of Quality of Life in Adult ScoliosisThis is a multicenter study evaluating the effectiveness of nonoperative and operative treatments.NCT00854828·Chicago, Illinois and 8 others

Active not recruitingA Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)The main objective of the study is to compare the efficacy of tarlatamab in combination with durvalumab, carboplatin and etoposide to the combination of durvalumab, carboplatin…NCT07005128·Casa Grande, Arizona and 163 others

TerminatedSafety and Tolerability of ABM-1310 in Patients With Advanced Solid TumorsThis is a Phase I, First-In-Human, open label, dose escalation and dose expansion study to evaluate the safety, tolerability, pharmacokinetics, and preliminary anti-cancer…NCT04190628·San Francisco, California and 7 others

CompletedA Study of Atezolizumab in Combination With Carboplatin + Paclitaxel or Carboplatin + Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower131]This randomized, open-label study will evaluate the safety and efficacy of atezolizumab (MPDL3280A) in combination with carboplatin + paclitaxel or carboplatin + nab-paclitaxel…NCT02367794·Chandler, Arizona and 241 others

CompletedA Double-Blind Study to Evaluate the Efficacy and Safety of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome)This Phase 3 study will evaluate the efficacy and safety of 2.0 mg/kg/week BMN 110 and 2.0 mg/kg/every other week BMN 110 in patients with mucopolysaccharidosis IVA (Morquio A…NCT01275066·Oakland, California and 27 others

PreviousPage 251 of 891Next

in Chicago

Heart Diseasein Chicago